On 2025-05-08, Entrada Therapeutics, Inc. (TRDA) announced earnings per share of $-0.42 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.78.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.83 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.78 | $-0.42 |
| 2025-02-27 | 2024-12-31 | $-0.66 | $0.03 |
| 2024-11-05 | 2024-09-30 | $-0.67 | $-0.35 |
| 2024-08-13 | 2024-06-30 | $0.65 | $1.55 |
| 2024-05-07 | 2024-03-31 | $-0.38 | $0.68 |
| 2024-03-13 | 2023-12-31 | $-0.07 | $-0.29 |
| 2023-11-07 | 2023-09-30 | $-0.55 | $1.02 |
| 2023-08-08 | 2023-06-30 | $-0.43 | $-0.78 |
| 2023-05-10 | 2023-03-31 | $-0.77 | $-0.21 |
| 2023-03-06 | 2022-12-31 | $-0.84 | $-0.79 |
| 2022-11-07 | 2022-09-30 | -- | $-0.80 |
| 2022-08-11 | 2022-06-30 | -- | $-0.74 |
| 2022-05-12 | 2022-03-31 | -- | $-0.69 |
| 2022-03-15 | 2021-12-31 | -- | $-0.89 |
| 2021-12-09 | 2021-09-30 | -- | $-9.78 |